# Phase 17 — Cascading Prescription Builder QA Validation Report

**Date:** April 8, 2026
**Phase:** Phase 17 — Cascading Prescription Builder (WO-82 + WO-83 + WO-84)
**Application:** CompoundIQ Clinic App
**URL:** https://functional-medicine-infrastructure.vercel.app
**Page:** `/new-prescription/search` (Configure Prescription)
**Tester:** Claude (Automated QA)

---

## Summary

**Overall Result: ALL 8 TESTS PASS (0 blocking, 0 non-blocking)**

Phase 17 delivers the complete cascading prescription builder with structured sig generation, titration scheduling, cycling protocols, and free-text override. All three work orders (WO-82 Hierarchical Medication Catalog, WO-83 Cascading Dropdown UI, WO-84 Structured Sig Builder + Titration/Cycling Engine) are validated and functional. The builder correctly generates sigs with timing, duration, titration parameters, and cycling patterns. Mode toggles are mutually exclusive. Free-text editing preserves and restores auto-generated sigs. The full flow passes all configuration through URL parameters to the margin builder, where the sig is pre-filled. Regression tests confirm DEA Schedule 3 warnings, FDA Category 2 alerts, salt/ester form label rename, and multi-formulation selection all remain intact.

---

## Results Table

| Test | Description | WO | Result |
|------|-------------|-----|--------|
| 1 | Standard Sig with Timing + Duration | WO-84 | PASS |
| 2 | Titration Mode — LDN Protocol | WO-84 | PASS |
| 3 | Cycling Mode — Peptide Protocol | WO-84 | PASS |
| 4 | Mode Mutual Exclusivity | WO-84 | PASS |
| 5 | Free Text Override | WO-84 | PASS |
| 6 | Full Flow to Margin Builder | WO-82/83/84 | PASS |
| 7 | Salt/Ester Form + DEA Warning (Regression) | WO-83 | PASS |
| 8 | FDA Alert (Regression) | WO-83 | PASS |

---

## Test 1 — Standard Sig with Timing + Duration

**Medication:** Semaglutide 5mg/mL Injectable
**Configuration:** 10 units, Once weekly (QW), Timing: "In the morning", Duration: "For 30 days"

| Verification | Result |
|-------------|--------|
| Section header reads "DOSE & DIRECTIONS" | PASS |
| Timing dropdown has 9 options (no timing, At bedtime, In the morning, With breakfast, With food, On an empty stomach, 30 min before meals, After meals, In the evening) | PASS |
| Duration dropdown has 8 options (no duration, 7/14/30/60/90 days, Ongoing, Custom) | PASS |
| Mode toggle pills present: Standard (active/blue), Titration, Cycling | PASS |
| Auto-generated sig: "Inject 10 units (0.10mL / 0.50mg) subcutaneous once weekly in the morning for 30 days" | PASS |
| Character counter: 85 / 1000 characters | PASS |
| Dose math: 10 units / 100 = 0.10mL x 5mg/mL = 0.50mg | PASS |

---

## Test 2 — Titration Mode (LDN Protocol)

**Medication:** Naltrexone HCL 1mg/mL Oral Solution (LDN)
**Configuration:** Frequency: At bedtime (QHS), Timing: "At bedtime"
**Mode:** Titration

| Verification | Result |
|-------------|--------|
| Titration button turns blue when active | PASS |
| Amber-bordered panel appears: "Titration Schedule — Dose Escalation" | PASS |
| Fields: Start at (amount + unit), Increase by (amount + unit), Every (interval), Up to (amount + unit + "as tolerated") | PASS |
| Every dropdown options: Every 3-4 days, Every week, Every 2 weeks, Every 4 weeks, Custom | PASS |
| Set: Start at 0.1 mL, Increase by 0.1 mL, Every 3-4 days, Up to 0.5 mL | PASS |
| Auto-generated sig: "Take 0.1mL (0.10mg) oral at bedtime. Titrate up by 0.1mL every 3-4 days as tolerated up to 0.5mL (0.50mg)" | PASS |
| No duplicate "at bedtime" in sig | PASS |
| Character counter: 105 / 1000 characters | PASS |
| "Titration" badge appears next to sig | PASS |

---

## Test 3 — Cycling Mode (Peptide Protocol)

**Medication:** BPC-157 5mg/mL Injectable
**Configuration:** 1 mg, Once daily (QD)
**Mode:** Cycling

| Verification | Result |
|-------------|--------|
| Cycling button turns blue when active | PASS |
| Blue-bordered panel appears: "Cycling Schedule — On/Off Pattern" | PASS |
| Fields: days on / days off, Cycle for (amount + unit + "then reassess"), Rest period | PASS |
| Set: 5 days on / 2 days off, Cycle for 6 weeks | PASS |
| Auto-generated sig: "Inject 20 units (0.20mL / 1mg) subcutaneous once daily, 5 days on / 2 days off, for 6 weeks then reassess" | PASS |
| Dose math: 1mg / 5mg/mL = 0.20mL x 100 = 20 units | PASS |
| Character counter: 105 / 1000 characters | PASS |
| "Cycling" badge appears next to sig | PASS |

---

## Test 4 — Mode Mutual Exclusivity

| Action | Expected | Result |
|--------|----------|--------|
| Click Titration | Titration panel visible, Cycling panel hidden | PASS |
| Click Cycling | Cycling panel visible, Titration panel hidden | PASS |
| Click Standard | Both panels hidden | PASS |

Modes are fully mutually exclusive. Only one mode panel can be visible at a time. Switching modes immediately hides the previous panel and shows the new one (or hides all for Standard).

---

## Test 5 — Free Text Override

| Action | Expected | Result |
|--------|----------|--------|
| Click "Edit manually" | Editable textarea appears, pre-filled with auto-generated sig | PASS |
| "Use auto-generated" link appears in header | Link visible | PASS |
| Edit sig text (added ". Take with food. Rotate injection sites.") | Textarea updates, counter shows 95/1000 | PASS |
| Click "Use auto-generated" | Textarea replaced by read-only sig preview, original auto-generated sig restored (54 chars) | PASS |
| "Edit manually" link reappears | Link visible | PASS |

---

## Test 6 — Full Flow to Margin Builder

**Medication:** Semaglutide 5mg/mL Injectable
**Configuration:** 10 units, QW, Timing: "In the morning", Strive Pharmacy, 5mL vial, 0 refills

| Verification | Result |
|-------------|--------|
| Medication → Salt form auto-skip → Formulation → Dose & Directions → Pharmacy → Quantity → Continue | PASS |
| URL params include: formulation_id, dose=10 units, frequency=QW, sigText with "in the morning" | PASS |
| Margin builder: Wholesale $150.00, Semaglutide 5mg/mL, via Strive Pharmacy | PASS |
| Retail Price: $210.00 (1.5x default), multiplier buttons (1.5x, 2x, 2.5x, 3x) | PASS |
| Margin Summary: 28.6% margin, $9.00 platform fee (15% of margin), $51.00 clinic margin | PASS |
| Sig (Prescription Directions) textarea pre-filled: "Inject 10 units (0.10mL / 0.50mg) subcutaneous once weekly in the morning" | PASS |
| Character counter: 73 characters | PASS |
| Action buttons: "Add & Search Another", "Review & Send", "Save as Draft — Provider Signs Later" | PASS |

---

## Test 7 — Salt/Ester Form + DEA Warning (Regression)

**Medication:** Testosterone

| Verification | Result |
|-------------|--------|
| Search "Test" → Testosterone appears with red "DEA 3" badge in dropdown | PASS |
| After selection: amber/red banner "DEA Schedule 3 — Controlled substance. EPCS requirements apply at signing." | PASS |
| Section label reads "SALT / ESTER FORM" (renamed from "FORM") | PASS |
| Two salt form pills: Testosterone Cypionate, Testosterone Enanthate | PASS |
| Select Cypionate → two formulations appear | PASS |
| Formulation 1: Testosterone Cypionate 200mg/mL Injectable — Grapeseed Oil — Sterile | PASS |
| Formulation 2: Testosterone Cypionate 200mg/mL in MCT Oil — MCT Oil — Sterile | PASS |

---

## Test 8 — FDA Alert (Regression)

**Medication:** BPC-157

| Verification | Result |
|-------------|--------|
| Search "BPC" → BPC-157 appears with amber "Category 2" badge in dropdown | PASS |
| After selection: amber banner "FDA Alert: Category 2 — FDA categorized BPC-157 as a substance presenting significant safety risks (immunogenicity/angiogenesis). Provider must acknowledge before prescribing." | PASS |
| Salt form auto-skipped (only one salt form) | PASS |
| Formulation: BPC-157 5mg/mL Injectable — Injectable Solution — Subcutaneous — Sterile | PASS |

---

## WO-84 New UI Elements Catalog

### DOSE & DIRECTIONS Section (renamed from DOSE & FREQUENCY)

**Timing Dropdown (9 options):**
(no timing), At bedtime, In the morning, With breakfast, With food, On an empty stomach, 30 min before meals, After meals, In the evening

**Duration Dropdown (8 options):**
(no duration), For 7 days, For 14 days, For 30 days, For 60 days, For 90 days, Ongoing, Custom...

**Mode Toggle Pills:**
Standard (default, blue when active) | Titration (blue when active) | Cycling (blue when active)

### Titration Panel
- Border: Amber/yellow
- Header: "Titration Schedule — Dose Escalation"
- Fields: Start at (amount + unit), Increase by (amount + unit), Every (interval select), Up to (amount + unit + "as tolerated")
- Every options: Every 3-4 days, Every week, Every 2 weeks, Every 4 weeks, Custom...

### Cycling Panel
- Border: Blue/periwinkle
- Header: "Cycling Schedule — On/Off Pattern"
- Fields: days on / days off, Cycle for (amount + unit + "then reassess"), Rest period (free text, placeholder "e.g. 2-4 weeks")

### SIG (DIRECTIONS) Section
- Auto-generated sig in read-only italicized preview by default
- "Edit manually" link → switches to editable textarea
- "Use auto-generated" link → reverts to auto-generated sig
- Character counter: N / 1000 characters
- Mode badge (Titration/Cycling) appears when applicable

---

## Conclusion

Phase 17 is fully functional. WO-84's Structured Sig Builder correctly extends the WO-83 cascading dropdown builder with timing, duration, titration schedules, and cycling protocols. All three modes (Standard, Titration, Cycling) generate accurate, clinically meaningful sig text with correct dose/volume/mass conversions. The free-text override provides flexibility while preserving the auto-generated baseline. The full prescription flow — from medication search through salt form selection, formulation, dose configuration, pharmacy pricing, to the margin builder — works end-to-end with all parameters correctly passed via URL. Regression tests confirm that previously-delivered features (DEA warnings, FDA alerts, salt/ester form labels, multi-formulation selection) remain intact. Ready for production.
